EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea

Brígida Santos, Catarina Ginete, Elisângela Gonçalves, Mariana Delgadinho, Armandina Miranda, Paula Faustino, Ana Paula Arez, Miguel Brito

Blood Cells, Molecules, and Diseases · 2024

DOI: 10.1016/j.bcmd.2023.102822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2024. Verfasst von Brígida Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação em Saúde de Angola (CISA), Caxito, Angola; Hospital Pediátrico David Bernardino (HPDB), Luanda, Angola; Global Health and Trop…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Malaria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sickle Cell Anemia (SCA) is a monogenic disease, although its severity and response to treatment are very heterogeneous. OBJECTIVES: This study aims to characterize a cohort of Angolan children with SCA and evaluate their response to hydroxyurea (HU) treatment and the potential side effects and toxicity. METHODS: The study enrolled 215 patients between 3 and 12 years old before and after the administration of HU, at a fix dose of 20 mg/kg/day for 12 months. RESULTS: A total of 157 patients started HU medication and 141 of them completed the 12-month treatment. After initiating HU treatment, the frequency of clinical events decreased (transfusions 53.4 %, hospitalizations 47.1 %). The response to HU medication varied among patients, with some experiencing an increase in fetal hemoglobin (HbF) of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellMalariaChildHumansChild, PreschoolHydroxyureaAntisickling AgentsFetal Hemoglobin

Stichwörter der Autor:innen

AngolaFetal hemoglobinHydroxyureaMalariaSickle cell anemia

Substanzen

HydroxyureaAntisickling AgentsFetal Hemoglobin

Autor:innen und Institutionen

  • Centro de Investigação em Saúde de Angola (CISA), Caxito, Angola; Hospital Pediátrico David Bernardino (HPDB), Luanda, Angola; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovati…
  • H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal.
  • Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Lisbon,…
  • Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Lisbon, Portugal; Instituto de Saúde Ambiental (ISAMB), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Laboratório Associado TERRA, Faculdade…
  • Centro de Investigação em Saúde de Angola (CISA), Caxito, Angola; H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal. Electron…

Zitieren

APA

Santos, B., Ginete, C., Gonçalves, E., Delgadinho, M., Miranda, A., Faustino, P., Arez, A. P., & Brito, M. (2024). Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2023.102822

Vancouver

Santos B, Ginete C, Gonçalves E, Delgadinho M, Miranda A, Faustino P, et al. Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea. Blood Cells, Molecules, and Diseases. 2024. doi:10.1016/j.bcmd.2023.102822

BibTeX
@article{Santos2024,
  author = {Santos, Brígida and Ginete, Catarina and Gonçalves, Elisângela and Delgadinho, Mariana and Miranda, Armandina and Faustino, Paula and Arez, Ana Paula and Brito, Miguel},
  title = {Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2024},
  doi = {10.1016/j.bcmd.2023.102822}
}
Kostenlos starten →